What to expect when you take Lessina-21 and have Fibrillary glomerulonephritis?

Do you take Lessina-21 and have Fibrillary glomerulonephritis? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 21, 2018

299 reports have been studied.


Females aged 50 to 59 :

299 related reports were analyzed:

Most common symptoms:

Breast cancer
  • 5.35% for females aged 50 (±5) who take Lessina-21
Chest pain
  • 7.36% for females aged 50 (±5) who take Lessina-21
Fatigue
  • 5.02% for females aged 50 (±5) who take Lessina-21
Nausea
  • 10.03% for females aged 50 (±5) who take Lessina-21
Pulmonary embolism
  • 7.02% for females aged 50 (±5) who take Lessina-21
Weakness
  • 5.02% for females aged 50 (±5) who take Lessina-21

Most common co-existing conditions:

Birth control
  • 16.72% for females aged 50 (±5) who take Lessina-21
Depression
  • 5.35% for females aged 50 (±5) who take Lessina-21
Hormone replacement therapy
  • 6.02% for females aged 50 (±5) who take Lessina-21
Multiple sclerosis
  • 7.36% for females aged 50 (±5) who take Lessina-21
back to top

Males aged 50 to 59 :

0 related reports were analyzed:

Most common symptoms:

  • n/a

Most common co-existing conditions:

  • n/a
back to top

Do you take Lessina-21 and have Fibrillary glomerulonephritis:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

lessina-21

Lessina-21 has active ingredients of ethinyl estradiol; levonorgestrel. (latest outcomes from Lessina-21 5 users)

fibrillary glomerulonephritis

Fibrillary glomerulonephritis (progressive renal dysfunction with deposit in glomeruli) has been reported by people with high blood pressure, systemic lupus erythematosus, hot flush, supplementation therapy, high blood cholesterol (latest reports from 36 Fibrillary glomerulonephritis patients).

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.